SCM

Silverarc Capital Management Portfolio holdings

AUM $489M
This Quarter Return
+11.91%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
10 Year Return
AUM
$173M
AUM Growth
+$173M
Cap. Flow
+$22.9M
Cap. Flow %
13.3%
Top 10 Hldgs %
38.32%
Holding
115
New
19
Increased
26
Reduced
33
Closed
31
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RCKT icon
101
Rocket Pharmaceuticals
RCKT
$354M
-10,293 Closed -$456
RCUS icon
102
Arcus Biosciences
RCUS
$1.13B
0
RLMD icon
103
Relmada Therapeutics
RLMD
$37.2M
-46,729 Closed -$1.5K
SAGE
104
DELISTED
Sage Therapeutics
SAGE
0
SLRX icon
105
Salarius Pharmaceuticals
SLRX
$2.94M
-471,885 Closed -$500
SNDX icon
106
Syndax Pharmaceuticals
SNDX
$1.41B
-34,727 Closed -$596
VSTM icon
107
Verastem
VSTM
$569M
-1,049,357 Closed -$4.27K
WVE icon
108
Wave Life Sciences
WVE
$1.53B
-123,972 Closed -$826
XBI icon
109
SPDR S&P Biotech ETF
XBI
$5.07B
0
CERE
110
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-15,000 Closed -$1.66K
MDNA
111
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
-110,515 Closed -$333
KDNY
112
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-14,158 Closed -$12.8K
EVLO
113
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
0
TCRR
114
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-188,142 Closed -$3.09K
CHAQ.WS
115
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
-104,828 Closed -$85